alk-positive nsclc: ascend-4 trial
Published 5 years ago • 160 plays • Length 6:09Download video MP4
Download video MP3
Similar videos
-
6:37
ascend-4: upfront ceritinib in alk-rearranged nsclc
-
5:15
results of ascend-4 trial of ceritinib versus chemotherapy in alk nsclc patients
-
4:31
alk-positive nsclc: alex trial
-
1:23
ascend-1 and ascend-2: ceritinib for alk-rearranged nsclc and baseline brain metastases
-
2:51
highlights on adjuvant alectinib in early alk positive nsclc: the alina study
-
1:10:58
alk 101 part 4: i have cancer progression- now what?!
-
1:15:42
alk 101 part 5: life after lorlatinib
-
3:12
last signs of lung cancer before death
-
4:23
alecensa: targeted therapy for alk-positive lung cancer
-
1:04
ascend-2 and ascend-3 trials: ceritinib in alk-rearranged nsclc with brain metastases
-
1:57
dr. shaw on sequencing strategies in alk-positive nsclc
-
5:19
ascend-5: ceritinib for alk positive nsclc previously treated with crizotinib
-
1:48
dr. chow on the use of ceritinib in alk nsclc metastatic to the brain
-
6:51
progression in alk nsclc after frontline therapy
-
8:24
second-line treatment for alk-positive nsclc
-
8:51
alk-positive nsclc
-
5:21
ceritinib alternative dosing for alk nsclc
-
3:13
available therapies for alk-rearranged nsclc
-
6:04
case study: progression on alk inhibitors in nsclc
-
1:17
dr. xia on the frontline treatment landscape of alk-positive nsclc
-
8:24
second-line treatment for alk-positive nsclc
-
0:56
nautika1: safety and tolerability of neoadjuvant alectinib in alk-positive nsclc